AcuCort secures renewed FDA fee waiver ahead of planned NDA submission
Yarrow Bioscience completes VYNE merger and begins Phase 2 trial of YB-101
Asymchem's DH2 site completes first FDA inspection for continuous manufacturing of API
Par Health launches generic version of Janumet XR tablets in US
FDA approves Furoscix ReadyFlow for at-home treatment of edema
FDA grants Fast Track designation to Lundbeck's narcolepsy candidate Lu AH69593